US 11166936
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity
granted A61KA61K31/136A61K31/352
Quick answer
US patent 11166936 (Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity) held by Auransa Inc. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Auransa Inc.
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/136, A61K31/352, A61K31/353, A61K31/404